Tpcera

Shutdown

Website unreachable since Oct 16, 2026

The startup develops immunomodulatory compounds for the treatment of autoimmune diseases, utilizing both subcutaneous and oral administration methods to shift the immune response from inflammatory to anti-inflammatory states. This approach enables healthcare professionals to effectively manage patient conditions with greater ease and precision.

Traction –/10

Jerusalem, Israel · HQ

Biotechnology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup develops immunomodulatory compounds for the treatment of autoimmune diseases, utilizing both subcutaneous and oral administration methods to shift the immune response from inflammatory to anti-inflammatory states. This approach enables healthcare professionals to effectively manage patient conditions with greater ease and precision.